Dr. David Vanyo, an internist at HLA San Carlos Hospital: “Hepatitis is an inflammation of the liver that can cause health problems and even death.”

MARINA ALTA ENTERPRISES IN MARINA PLAZA.

HLA HOSPITAL SAN CARLOS DE DENIA.

He World Hepatitis Day 2024 celebrated annually July 28th since 2010, and from the HLA San Carlos de Denia Hospital we want to join this initiative to highlight the importance of fighting this viral disease that causes high morbidity and mortality worldwide.

Under the motto “It’s time to act” The need for concerted action to expand access to diagnostics and treatment in all countries is being proclaimed.

According to Dr. David Vanyo, Manager and specialist in internal medicine at the HLA San Carlos Hospital in Denia, “Hepatitis is an inflammation of the liver that can cause a number of health problems and even death. The liver silently performs more than 500 vital functions every day to keep us alive. The problem is that viral hepatitis infection usually goes unnoticed and symptoms only appear in the later stages of the disease. In addition to viral hepatitis (usually viruses A, B and C), there are other factors that can cause hepatitis, such as excessive alcohol consumption, certain medications, autoimmune diseases and other types of infections.

Common symptoms of hepatitis include fatigue, loss of appetite, abdominal pain, jaundice (yellowing of the skin and eyes), dark urine, and light-colored stools. If you suspect hepatitis, you should seek immediate medical attention for an accurate diagnosis and appropriate treatment.

According to the latest data from World Health Organization (WHO), in 2022, about 254 million people had hepatitis B and another 50 million had hepatitis C. Most chronic hepatitis B and C infections occurred in people aged 30 to 54 years, with men accounting for 58% of cases.

There are global gaps in hepatitis detection and treatment. In 2022, only 13% of people with chronic hepatitis B were diagnosed and about 3% were receiving antiviral treatment. For hepatitis C, 36% were diagnosed and 20% were treated. These figures fall short of the WHO global targets of helping 80% of people with chronic hepatitis B and C by 2030.

Despite this, there have been gains, reflecting a moderate and steady increase in diagnosis and treatment volumes since the last measurement recorded in 2019.

An important issue is the need to end stigma and discrimination associated with hepatitis at the social and cultural level.

For all these reasons, WHO has developed an ambitious plan to eliminate hepatitis as a public health problem by 2030, based on the Global Action Plan for the Prevention and Control of Viral Hepatitis. According to the World Health Organization, about 4.5 million premature deaths could be prevented by 2030 through vaccination, prevention strategies, increased access to diagnostic tests, improved access to medicines, and education campaigns. The global strategy, endorsed by all Member States, proposed to reduce new infections by 90% and hepatitis-related deaths by 65%.

At the HLA San Carlos Hospital in Denia we have a large team of professionals and resources with which we can guide and assist in the prevention, management and treatment of viral hepatitis.

About HLA Hospital Group

HLA Hospital Group is one of the largest healthcare providers in Spain. It comprises 18 hospitals and 38 multidisciplinary medical centres with reference departments for the latest treatments, working together to provide access to high-quality medical care.

With 1,300 hospital beds and more than 40 years of experience, HLA is a benchmark in inpatient and outpatient care. Its professionals guarantee a model of care based on excellence, innovation, responsibility and humane and attentive treatment of the patient.

-More news from the San Carlos Hospital in La Marina Plaza.

-Related news in the HEALTH AND WELL-BEING LA MARINA PLAZA section.

Direct Anterior Approach to the Hip: An Advanced Surgical Technique for Total Hip Arthroplasty